Fenoldopam Reduces the Need for Renal Replacement Therapy and In-Hospital Death in Cardiovascular Surgery: A Meta-Analysis
- 1 February 2008
- journal article
- research article
- Published by Elsevier in Journal of Cardiothoracic and Vascular Anesthesia
- Vol. 22 (1), 27-33
- https://doi.org/10.1053/j.jvca.2007.07.015
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Fenoldopam Reduces the Incidence of Renal Replacement Therapy After Cardiac SurgeryJournal of Cardiothoracic and Vascular Anesthesia, 2008
- A Comparison of Fenoldopam with Dopamine and Sodium Nitroprusside in Patients Undergoing Cross-Clamping of the Abdominal AortaAnesthesia & Analgesia, 2006
- Renoprotective Action of Fenoldopam in High-Risk Patients Undergoing Cardiac SurgeryCirculation, 2005
- Fenoldopam Prophylaxis of Postoperative Acute Renal Failure in High-Risk Cardiac Surgery PatientsThe Annals of Thoracic Surgery, 2004
- A simple hint to improve Robinson and Dickersin's highly sensitive PubMed search strategy for controlled clinical trialsInternational Journal of Epidemiology, 2004
- Measuring inconsistency in meta-analysesBMJ, 2003
- The effects of fenoldopam on renal function in patients undergoing elective aortic surgeryEuropean Journal of Anaesthesiology, 2002
- Multicenter clinical trial of recombinant human insulin-like growth factor I in patients with acute renal failureKidney International, 1999
- Anaritide in Acute Tubular NecrosisNew England Journal of Medicine, 1997
- Responses to hemorrhagic arterial pressure reduction in different ischemic renal failure modelsKidney International, 1994